1.6.2011 | Afbrigði í geislaskautum og DNA viðgerð í BRCA2 arfblendnum frumum | Jenný Björk Þorsteinsdóttir 1978- |
10.10.2024 | ALKBH3 and FTO: New Epitranscriptomic Regulators of DNA Double-Strand Break Response | Birta Dröfn Jónsdóttir 1996- |
23.2.2015 | Alterations of the FHIT gene in breast cancer: Association with tumor progression and patient survival | Sigurður Ingvarsson 1956-; Bjarnveig I. Sigbjörnsdóttir 1968-; Huiping Chen, 1965-; Jón Gunnlaugur Jónasson 1956-; Bjarni A. Agnarsson 1952- |
22.5.2015 | Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance | Sigurður Ingvarsson 1956-; Kristján Skúli Ásgeirsson 1968-; Jón Gunnlaugur Jónasson 1956-; Laufey Tryggvadóttir 1954-; Kristrún Auður Ólafsdóttir 1941-; Jenný Rut Sigurgeirsdóttir 1972-; Helga M. Ögmundsdóttir 1948- |
29.5.2015 | Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer | Sigurður Ingvarsson 1956-; Huiping Chen, 1965-; Jón Gunnlaugur Jónasson 1956-; Bjarni A. Agnarsson 1952-; Bjarnveig I. Sigbjörnsdóttir 1968-; Huebner, Kay |
7.10.2008 | ASH2L. Rannsókn á tjáningu ASH2L (absent, small or homeotic discs-2-like) í völdum brjóstafrumulínum | Jóhanna Kristbjörg Helgadóttir 1986- |
17.10.2013 | Aurora A nuclear expression and telomere length in BRCA2 related breast cancer | Margrét Aradóttir 1987- |
26.5.2025 | Áhrif ATL2 á framgang brjóstakrabbameins | Nataliya Shabatura 2001- |
17.5.2024 | Áhrif greiningaraðferðar á stigun brjóstakrabbameina og horfur | Rakel Ósk Sigurðardóttir 2000- |
27.5.2011 | Áhrif sértæks Aurora-A kínasahindra á brjóstaþekjufrumulínur með stökkbreytingu í BRCA2 geninu | Stefanía Lind Stefánsdóttir 1984- |
15.5.2015 | Ákvarðast lyfjanæmi í BRCA1 vanvirkum frumulínum af TP53 stökkbreytingum? | Sæþór Pétur Kjartansson 1993- |
13.5.2016 | Áunnar erfðabreytingar í BRCA2 tengdum krabbameinum | Árni Johnsen 1991- |
26.1.2015 | The Brca1 and Brca2 proteins and tumor pathogenesis | Sigurður Ingvarsson 1956- |
5.6.2025 | Breast cancer whole-slide images used to predict homologous recombination deficiency, BRCA2 999del5 and TP53 mutations via weakly supervised deep learning | Ýr Ý Nhu Tran 2001- |
8.6.2015 | Breast cancer: introduction | Sigurður Ingvarsson 1956- |
25.4.2018 | Breast cell lines as models for isolation of therapeutically active exosomes | Helga Steen Snorradóttir 1989- |
15.5.2023 | Brjóstakrabbamein – tengsl BRCA2 stökkbreytingar við tímasetningu og staðsetningu fjarmeinvarpa | Helga Sif Guðmundsdóttir 2000- |
23.6.2022 | Cancer-related cognitive impairment and sleep problems in treatment-naïve cancer patients | Rebekka Steinarsdóttir 1993- |
9.1.2012 | Cellular and molecular mechanisms in breast morphogenesis and epithelial to mesenchymal transition | Valgarður Sigurðsson 1978- |
1.9.2008 | Chromosomal alterations and telomere dysfunction in breast tumours | Sigríður Klara Böðvarsdóttir 1971- |
20.5.2015 | Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer | Sigurður Ingvarsson 1956-; Bjarnveig I. Sigbjörnsdóttir 1968-; Gísli Ragnarsson 1948-; Bjarni A. Agnarsson 1952-; Huiping Chen, 1965-; Rósa Björk Barkardóttir 1958-; Valgarður Egilsson 1940- |
11.5.2015 | Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer | Sigurður Ingvarsson 1956-; Huiping Chen, 1965-; Jenný Rut Sigurgeirsdóttir 1972-; Jón Gunnlaugur Jónasson 1956-; Guðný Eiríksdóttir 1950-; Jónína Þuríður Jóhannsdóttir 1969-; Valgarður Egilsson 1940- |
15.4.2015 | Chromosome imbalance at the 3p14 region in human breast tumours: High frequency in patients with inherited predisposition due to BRCA2 | Sigurður Ingvarsson 1956-; Jón Þór Bergþórsson 1966-; Jónína Jóhannsdóttir 1954-; Aðalbjörg Jónasdóttir 1959-; Guðný Eiríksdóttir 1950-; Valgarður Egilsson 1940-; Rósa Björk Barkardóttir 1958-; Aðalgeir Arason 1957- |
27.6.2022 | Clinical evaluation of an Icelandic adaptation of Moving Forward : a post-treatment course offered to women who have completed treatment for breast cancer | Aron Haukur Hauksson 1988- |
14.4.2015 | Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations | Sigurður Ingvarsson 1956-; Tirkkonen, Mika; Óskar Þór Jóhannsson 1960-; Bjarni A. Agnarsson 1952-; Olsson, Håkan; Karhu, Ritva; Tanner, Minna; Isola, Jorma; Rósa Björk Barkardóttir 1958-; Borg, Åke; Kallioniemi, Olli-P. |